212 related articles for article (PubMed ID: 30671343)
21. Plasma aspartate aminotransferase (AST), glutamate dehydrogenase (GLDH) and gamma-glutamyl transpeptidase (GGT) activities in water buffaloes with experimental subclinical fasciolosis.
Yang Q; Mao WH; Ferre I; Bayón JE; Mao XZ; González-Gallego J
Vet Parasitol; 1998 Jul; 78(2):129-36. PubMed ID: 9735917
[TBL] [Abstract][Full Text] [Related]
22. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep.
Flanagan A; Edgar HW; Gordon A; Hanna RE; Brennan GP; Fairweather I
Vet Parasitol; 2011 Mar; 176(2-3):170-6. PubMed ID: 21112153
[TBL] [Abstract][Full Text] [Related]
24. Triclabendazole treatment in experimental goat fasciolosis: anthelmintic efficacy and influence in antibody response and pathophysiology of the disease.
Martínez-Moreno A; Jiménez V; Martínez-Cruz MS; Martínez-Moreno FJ; Becerra C; Hernández S
Vet Parasitol; 1997 Jan; 68(1-2):57-67. PubMed ID: 9066052
[TBL] [Abstract][Full Text] [Related]
25. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
[TBL] [Abstract][Full Text] [Related]
26. The serum glucose and beta-hydroxybutyrate levels in sheep with experimental Fasciola hepatica and Fasciola gigantica infection.
Phiri IK; Phiri AM; Harrison LJ
Vet Parasitol; 2007 Feb; 143(3-4):287-93. PubMed ID: 17011709
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the flukicide treatment policy for dairy cattle in Galicia (NW Spain).
Mezo M; González-Warleta M; Castro-Hermida JA; Ubeira FM
Vet Parasitol; 2008 Nov; 157(3-4):235-43. PubMed ID: 18774648
[TBL] [Abstract][Full Text] [Related]
28. Patent infections with Fasciola hepatica and paramphistomes (Calicophoron daubneyi) in dairy cows and association of fasciolosis with individual milk production and fertility parameters.
May K; Brügemann K; König S; Strube C
Vet Parasitol; 2019 Mar; 267():32-41. PubMed ID: 30878082
[TBL] [Abstract][Full Text] [Related]
29. Control of Fasciola gigantica with triclabendazole in Indonesian cattle.
Suhardono ; Widjajanti S; Stevenson P; Carmichael IH
Trop Anim Health Prod; 1991 Nov; 23(4):217-20. PubMed ID: 1686688
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of triclabendazole and other anthelmintics against Fasciola hepatica in controlled studies in cattle.
Richards RJ; Bowen FL; Essenwein F; Steiger RF; Büscher G
Vet Rec; 1990 Mar; 126(9):213-6. PubMed ID: 2316160
[TBL] [Abstract][Full Text] [Related]
31. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
Novobilský A; Amaya Solis N; Skarin M; Höglund J
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
[TBL] [Abstract][Full Text] [Related]
32. Anthelmintic suppression of Fasciola hepatica infections in sheep.
Taylor SM; Langridge SA; Kenny J
Vet Rec; 1994 Jul; 135(4):86-8. PubMed ID: 7975094
[TBL] [Abstract][Full Text] [Related]
33. Calicophoron daubneyi (Dinnik, 1962) (Digenea) in beef and dairy cattle in the Czech Republic: prevalence and drug efficacy.
Bastyrova Brutovska A; Vogalova P; Rost M; Sak B; Kvac M
Folia Parasitol (Praha); 2023 Jan; 70():. PubMed ID: 36625498
[TBL] [Abstract][Full Text] [Related]
34. First report and risk of infection of Fasciola hepatica (Linnaeus, 1761) in water buffaloes (Bubalus bubalis - Linnaeus, 1758) in Mexico.
Ojeda-Robertos NF; Peralta-Torres JA; Parra-Bracamonte GM; Cruz-González AR; Luna-Palomera C; Ulín-Yzquierdo C; Pires LA; Molento MB
Vet Parasitol Reg Stud Reports; 2022 Feb; 28():100682. PubMed ID: 35115121
[TBL] [Abstract][Full Text] [Related]
35. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
Novobilský A; Averpil HB; Höglund J
Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of triclabendazole (TCBZ) on the excretory-secretory products (ESP) of Fasciola spp parasites.
Farahnak A; Golmohamdi T; Eshraghian M
Acta Med Iran; 2012; 50(3):164-8. PubMed ID: 22418984
[TBL] [Abstract][Full Text] [Related]
37. Triclabendazole efficacy, prevalence, and re-infection of Fasciola hepatica in bovine and ovine naturally infected in the Andes of Ecuador.
Rodríguez-Hidalgo R; Calvopiña M; Romero-Alvarez D; Montenegro-Franco M; Pavon D; Pointier JP; Benítez-Ortiz W; Celi-Erazo M
Vet Parasitol Reg Stud Reports; 2024 Jan; 47():100947. PubMed ID: 38199691
[TBL] [Abstract][Full Text] [Related]
38. Phenotypes of intermediate forms of Fasciola hepatica and F. gigantica in buffaloes from Central Punjab, Pakistan.
Afshan K; Valero MA; Qayyum M; Peixoto RV; Magraner A; Mas-Coma S
J Helminthol; 2014 Dec; 88(4):417-26. PubMed ID: 23731975
[TBL] [Abstract][Full Text] [Related]
39. Fasciola spp. in Armenia: Genetic diversity in a global context.
Aghayan S; Gevorgian H; Ebi D; Atoyan HA; Addy F; Mackenstedt U; Romig T; Wassermann M
Vet Parasitol; 2019 Apr; 268():21-31. PubMed ID: 30981302
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
